InvestorsObserver
×
News Home

Is it Time to Dump 180 Life Sciences Corp (ATNF) Stock After it Is Up 37.11% in a Week?

Friday, May 19, 2023 09:53 AM | InvestorsObserver Analysts

Mentioned in this article

Is it Time to Dump 180 Life Sciences Corp (ATNF) Stock After it Is Up 37.11% in a Week?

180 Life Sciences Corp (ATNF) stock has risen 37.11% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
180 Life Sciences Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ATNF!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ATNF Stock Today?

180 Life Sciences Corp (ATNF) stock is trading at $1.33 as of 9:51 AM on Friday, May 19, a rise of $0.29, or 27.88% from the previous closing price of $1.04. The stock has traded between $1.14 and $1.42 so far today. Volume today is more active than usual. So far 2,919,157 shares have traded compared to average volume of 189,368 shares. To screen for more stocks like 180 Life Sciences Corp click here.

More About 180 Life Sciences Corp

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics. Click Here to get the full Stock Report for 180 Life Sciences Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App